Home
Renata

Renata Market Share Analysis for August 2026

At Renata, we are driven by a relentless commitment to advancing healthcare and improving patient lives.

Health > Pharmacy

Domainrenata-ltd.com

Year Founded1993

Employees> 10001

Annual Revenue--

Renata

Renata (including company regionals)

renata-ltd.com

See more website traffic and engagement information

Total visits to Renata's top domains

Understand Renata market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

renata-ltd.com66.1K

See more with Sales Intelligence

Avg. visit duration in Renata's top domains

Analyze Renata engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

renata-ltd.com00:07:06

See more with Sales Intelligence

Avg. pageviews on Renata's top domains

See how Renata keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

renata-ltd.com9.73

See more with Sales Intelligence

Renata top competitors by domain

Top similar sites in August 2026, ranked by their affinity

atabay.comCompany NameAtabay İlaç FabrikasıEmployees501 - 1000HQTurkey, GebzeAnnual revenue$100M - $200MTotal visits19.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Renata

These are the website technologies, by industry, used by Renata top domains

Payment & Currencies (8)

Cart Functionality

Widget (6)

Twemoji

Advertising (3)

Facebook Custom Audiences

Content Management System (3)

WordPress

More Technologies

8

See all

News & Signals from Renata

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRenata Ltd launches Cabergoline.Renata PLC expands global reach with UK launch of Cabergoline.

NewsRenata Ltd launches generic version of Cabergoline 0.5 mg, a medicine used for the treatment of hyperprolactinemia.Renata PLC, a leading pharmaceutical manufacturer in Bangladesh, has launched a generic version of Cabergoline 0.5 mg, a medicine used for the treatment of hyperprolactinemia and Parkinson's disease, in Australia.

NewsRenata Ltd receives financing of $60M in loan.Renata PLC, one of the leading drugmakers in the country, is set to secure a $60 million loan from the US-based International Finance Corporation (IFC) to bolster its working capital.